AlphaFold predicted structure
BMP6 · P22004

Mean pLDDT
68.9/ 100
Low
513 residues
Confidence breakdown
- Very high(≥ 90)32%
- Confident(70–90)27%
- Low(50–70)7%
- Very low(< 50)35%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
bone morphogenetic protein 6
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Iron metabolism disorders - NOT common HFE mutations
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownTangier disease
osteoarthritis, knee
Hernia
osteoarthritis, hip
Abnormality of the skeletal system
prostate adenocarcinoma
Hallux rigidus
Abnormal meniscus morphology
osteoarthritis
sleep apnea syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Bone morphogenetic protein 6
Growth factor of the TGF-beta superfamily that plays essential roles in many developmental processes including cartilage and bone formation (PubMed:31019025). Also plays an important role in the regulation of HAMP/hepcidin expression and iron metabolism by acting as a ligand for hemojuvelin/HJV (PubMed:26582087). Also acts to promote expression of HAMP, potentially via the interaction with its receptor BMPR1A/ALK3 (PubMed:30097509, PubMed:31800957). Initiates the canonical BMP signaling cascade by associating with type I receptor ACVR1 and type II receptor ACVR2B (PubMed:18070108). In turn, ACVR1 propagates signal by phosphorylating SMAD1/5/8 that travel to the nucleus and act as activators and repressors of transcription of target. Can also signal through non-canonical pathway such as TAZ-Hippo signaling cascade to modulate VEGF signaling by regulating VEGFR2 expression (PubMed:33021694)
BMP6 · P22004

Mean pLDDT
68.9/ 100
Low
513 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0